NO PFT system ANALYZER CLD 88 sp

FEV1/FVCPEFMV

<b>Product summary</b><br>The ANALYZER CLD 88 sp FeNO analyzer provides continuous, simultaneous measurement and display of exhaled nitric oxide (NO), expiratory flow and exhaled volume. Designed for clinical and research settings, the instrument delivers high sensitivity and reproducible results across patients from infants (>3 kg) to adults. It is CE MDD approved for clinical use and meets ATS/ERS 2005 recommendations for FeNO testing. Measurements can be performed online and offline; nasal and alveolar modes are supported.<br><br><b>Key features</b><br><ul><li>High sensitivity: detects NO concentrations down to 0.1 ppb (min. detectable concentration 0.06 ppb*).</li><li>Continuous, simultaneous display of NO, flow and exhaled volume for real‑time assessment.</li><li>Clinical approval (CE MDD) and compliance with ATS/ERS 2005 standards.</li><li>Suitable for newborns (>3 kg), children and adults; supports single-breath and multiple-breath protocols.</li><li>Capable of nasal and alveolar NO measurement; online and offline collection options.</li><li>Expandable with DENOX 88 module for NO-free air and expiratory flow control; offline NO collection kit available for remote testing.</li><li>Managed via SPIROWARE software for acquisition, configurable display, recording and data export.</li></ul><br><br><b>Applications</b><br><ul><li>Single-breath FeNO testing for cooperative patients</li><li>Multiple-breath protocols for non-cooperative patients (infants, young children)</li><li>Nasal nitric oxide measurements (nNO)</li><li>Offline NO sample collection for field or remote testing</li><li>Alveolar FeNO analysis for research and clinical assessment</li></ul><br><br><b>Your advantage</b><br><ul><li>Noninvasive assessment of airway inflammation (e.g., asthma)</li><li>Monitoring and verification of anti-inflammatory therapy</li><li>Identification of non-responders to treatment</li><li>Various flow ranges support advanced research (JNO, Calv calculations)</li><li>Screening for primary ciliary dyskinesia (PCD) using nasal NO</li><li>CE MDD 93/42 certified for clinical use; ATS/ERS standardized procedures (2005) compliant</li></ul><br><br><b>Specifications (table)</b><br>NO measurement: Measuring ranges 0.1–5000 ppb; Min. detectable concentration 0.06 ppb (*); Sensitivity down to 0.1 ppb; Zero drift <0.5 ppb per 6 h; Linearity ±1% full scale; Lag time <0.5 s (software compensated); Rise time (T90) <100 ms; Sample flow: selectable type 1 (110 ml/min) or type 3 (330 ml/min).<br><br>Flow measurement: Measuring ranges ±0.5 l/s (DSR small, VD 1.9 ml optional), ±1.5 l/s (DSR medium, VD 7.2 ml), ±16 l/s (Spirette); Min. detectable flow 0.6 ml; Accuracy ±2%.<br><br>General: Operating temperature 10–40 °C; Humidity tolerance 5–95% RH (non‑condensing); Internal maintenance-free ozone generator (no external supply gas required); Power consumption 400 VA; Supply voltage 100–240 V / 50–60 Hz; Interface RS-232; Weight 24 kg; Dimensions HxWxD: 135 x 500 x 540 mm.<br><br><b>System requirements</b><br>PC with modern multi-core processor (Intel Core or AMD Ryzen series, dual-core minimum), Microsoft Windows 11, .NET Framework 4.8, Microsoft Visual C++ 2015-2019 Redistributable, 4 GB RAM (8 GB recommended), 10 GB free disk space, DirectX 11 capable graphics, HD display (≥1280×720), USB 2.0 port. Compliant with EU MDR 2017/745 and EN 60601-1 safety standard.<br><br><b>System includes</b><br>ANALYZER CLD 88 sp, integrated ultrasonic spirometer, sample tube type 3, mains and RS-232 cables, operator's manual, SPIROWARE 3.x software. (Computer, printer, NO calibration gases and NO-free air supply are not included).<br><br><b>Regulatory information</b><br>The ANALYZER CLD 88 sp is a Class IIa medical device; CE 0483.<br><br><b>Technical specifications</b><br><ul><li>NO measuring range: 0.1–5000 ppb; Min. detectable concentration 0.06 ppb (*)</li><li>NO detection sensitivity: down to 0.1 ppb</li><li>Zero drift: <0.5 ppb per 6 h</li><li>Linearity: ±1% full scale</li><li>Lag time: <0.5 s (software compensated); Rise time (T90): <100 ms</li><li>Sample flow options: type 1 (110 ml/min) or type 3 (330 ml/min)</li><li>Flow measurement ranges: ±0.5 l/s (DSR small), ±1.5 l/s (DSR medium), ±16 l/s (Spirette)</li><li>Min. detectable flow: 0.6 ml; Flow accuracy: ±2%</li><li>Operating temperature: 10–40 °C; Humidity: 5–95% RH (non‑condensing)</li><li>Internal maintenance-free ozone generator (no external supply gas required)</li><li>Power consumption: 400 VA; Supply voltage: 100–240 V / 50–60 Hz</li><li>Interface: RS-232; Weight: 24 kg; Dimensions (HxWxD): 135 x 500 x 540 mm</li><li>Software requirements: Windows 11, .NET Framework 4.8, Visual C++ redistributable, 4–8 GB RAM, 10 GB disk, DirectX 11 capable graphics, USB 2.0</li><li>Intended use: FeNO testing from newborns (>3 kg) to adults; single and multiple breath testing; nasal and alveolar NO measurement; online and offline operation</li></ul>